A review of anabolic therapies for osteoporosis

por Lane, Nancy E, Kelman, Ariella
Publicado 2003

Continued Access to Investigational Medicinal Products for Clinical Trial Participants—An Industry Approach

por KELMAN, ARIELLA, KANG, ANNA, CRAWFORD, BRIAN
Publicado 2019

Communicating laboratory test results for rheumatoid factor: what do patients and physicians want?

por Kelman, Ariella, Robinson, Caroline O, Cochin, Elisenda, Ahluwalia, Nina J, Braverman, Julia, Chiauzzi, Emil, Simacek, Kristina
Publicado 2016

Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab

por Rubbert-Roth, Andrea, Sebba, Anthony, Brockwell, Laura, Kelman, Ariella, Porter-Brown, Benjamin, Pulley, Jennifer, Napalkov, Pavel, van Vollenhoven, Ronald F
Publicado 2016

Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial

por Burmester, Gerd R, Rigby, William F, van Vollenhoven, Ronald F, Kay, Jonathan, Rubbert-Roth, Andrea, Kelman, Ariella, Dimonaco, Sophie, Mitchell, Nina
Publicado 2016